GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Gross Margin %

Dr Lalchandani Labs (BOM:541299) Gross Margin % : 52.97% (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Dr Lalchandani Labs's Gross Profit for the six months ended in Sep. 2023 was ₹14.44 Mil. Dr Lalchandani Labs's Revenue for the six months ended in Sep. 2023 was ₹27.26 Mil. Therefore, Dr Lalchandani Labs's Gross Margin % for the quarter that ended in Sep. 2023 was 52.97%.

Warning Sign:

Dr Lalchandani Labs Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.5%.


The historical rank and industry rank for Dr Lalchandani Labs's Gross Margin % or its related term are showing as below:

BOM:541299' s Gross Margin % Range Over the Past 10 Years
Min: 39.75   Med: 68.36   Max: 88.43
Current: 66.77


During the past 11 years, the highest Gross Margin % of Dr Lalchandani Labs was 88.43%. The lowest was 39.75%. And the median was 68.36%.

BOM:541299's Gross Margin % is ranked better than
74.88% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.55 vs BOM:541299: 66.77

Dr Lalchandani Labs had a gross margin of 52.97% for the quarter that ended in Sep. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Dr Lalchandani Labs was -2.50% per year.


Dr Lalchandani Labs Gross Margin % Historical Data

The historical data trend for Dr Lalchandani Labs's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Gross Margin % Chart

Dr Lalchandani Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.43 81.16 63.10 73.62 75.90

Dr Lalchandani Labs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.63 90.84 70.46 80.40 52.97

Competitive Comparison of Dr Lalchandani Labs's Gross Margin %

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's Gross Margin % falls into.



Dr Lalchandani Labs Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Dr Lalchandani Labs's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=38.3 / 50.402
=(Revenue - Cost of Goods Sold) / Revenue
=(50.402 - 12.148) / 50.402
=75.90 %

Dr Lalchandani Labs's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=14.4 / 27.261
=(Revenue - Cost of Goods Sold) / Revenue
=(27.261 - 12.82) / 27.261
=52.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Dr Lalchandani Labs  (BOM:541299) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Dr Lalchandani Labs had a gross margin of 52.97% for the quarter that ended in Sep. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Dr Lalchandani Labs Gross Margin % Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs (BOM:541299) Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines